Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6 GBX | +14.29% | +37.14% | +140.00% |
11:34am | AIM WINNERS & LOSERS: Arecor Therapeutics dives on funding needs | AN |
10:38am | Allergy Therapeutics welcomes peanut allergy vaccine trial results | AN |
Sales 2022 | 72.77M 92.43M | Sales 2023 | 59.59M 75.69M | Capitalization | 7.13M 9.06M |
---|---|---|---|---|---|
Net income 2022 | -13M -16.51M | Net income 2023 | -43M -54.62M | EV / Sales 2022 | 1.7 x |
Net cash position 2022 | 9.99M 12.68M | Net Debt 2023 | 21.14M 26.86M | EV / Sales 2023 | 0.47 x |
P/E ratio 2022 |
-9.69
x | P/E ratio 2023 |
-0.16
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 6.79% |
1 day | +10.42% | ||
1 week | +32.50% | ||
Current month | +43.14% | ||
1 month | +84.03% | ||
3 months | +122.96% | ||
6 months | +189.85% | ||
Current year | +131.88% |
Managers | Title | Age | Since |
---|---|---|---|
Manuel Llobet
CEO | Chief Executive Officer | 60 | 09-06-30 |
Shaun Furlong
DFI | Director of Finance/CFO | - | 22-03-31 |
Murray Skinner
CTO | Chief Tech/Sci/R&D Officer | - | 03-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 17-06-05 | |
Peter Jensen
CHM | Chairman | 73 | 10-09-30 |
Anthony Parker
BRD | Director/Board Member | - | 22-12-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 6 | +14.29% | 4 648 143 |
24-06-07 | 5.25 | 0.00% | 86,598 |
24-06-06 | 5.25 | +0.96% | 1,816,018 |
24-06-05 | 5.2 | +4.00% | 2,751,957 |
24-06-04 | 5 | +14.29% | 1,565,971 |
Delayed Quote London S.E., June 10, 2024 at 04:48 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+131.88% | 318M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+1.22% | 22.78B | |
-11.07% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- AGY Stock